Variables Influencing the Thrombostat 4000: Recommended Standardization

Abstract

The in vitro bleeding test (IVBT) (Thrombostat 4000) was performed on blood samples from healthy blood donors using a “preliminary standard test.” Only one factor of the test procedure was changed each time.

We found the following parameters to have a significant influence on the test results: time interval between sampling and testing, diameter of the filter's aperture, capillary diameter, aggregating agents and their concentration, temperature of the blood and cartridges, method of drying the capillaries, the aspiration pressure, and the hematocrit of the blood sample. According to our data, we propose a standard IVBT for routine application and modifications for special diagnostic use.

Keywords

primary hemostasis - bleeding time - Thrombostat - hematocrit - rheology

• References

• 1 Dietrich G, Kretschmer V, Schikor B, Söhngen D. Der in-vitro Blutungstest (lVBT)—Eine empfindliche Methode zum Nachweis von Plättchenfunktionsstörungen bei Thrombozytenspendern. Beitr Infusionsther 26: 142-146 1990;
• 2 Dietrich G, Kretschmer V. Primary hemostatsis in hemodilution 1. influence of the hematocrit. Infusionsther 17: 212-213 1990;
• 3 Kretschmer V, Schikor B, Söhngen D, Dietrich G. In vitro bleeding test—a simple method for the detection of aspirin effects on platelet function. Thromb Res 56: 593-602 1989;
• 4 Kretschmer V, Dietrich G, Huss B, Langen B, Keller P, Heymann J, Pflüger K-H. Determination of bleeding risk in thrombocytopenic patients under platelet substitution. Infusionsther 18 ((Suppl)2) 47 1991;
• 5 Dietrich G, Kretschmer V. Präoperatives Screening der Thrombozytenfunktion mit dem In-vitro-Blutungstest. Lab Med 15: 247 1991;
• 6 Dietrich G, Kretschmer V, Schikor B, Söhngen D. Der In-vitroBlutungstest (lVBT)—eine enipfindliche Methode zum Nachweis von Plättchenfunktionsstörungen bei Thrombozytenspendern. Beiras Infusionsther 26: 142-146 1990;
• 7 Weippert-Kretschmer M, Witte M, Budde U, Vigh T, Kretschmer V, Scharrer I. The in vitro bleeding test (lVBT)—a sensitive screening test for von Willebrand's disease. Semin Thromb Hemost (this issue)
• 8 Escolar G, Garrido M, Mazzara R, Castillo R, Ordinas A. Experimental basis for the use of red cell transfusions in the management of anemic-thrombocytopenic patients. Transfusion 28: 406-411 1988;
• 9 Hellem AJ, Borchgrevink CF, Ames SB. The role ofred cells in haemostasis: the relation between haematocrit, bleeding times and platelet adhesiveness. Br J Haematol 7: 42 1961;
• 10 Reimers RC, Sutera SP, Joist JH. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. Blood 64: 1200-1206 1984;
• 11 Santos TM, Vall L, Aznar J, Perez-Requejo JL. Role of red blood cells in the early stages of platelet activation by collagen. Thromb Haemost 56: 376-377 1986;
• 12 Turitto VT, Baumgartner HR. Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells. Microvas Res 9: 335-344 1975;
• 13 Turitto VT, Weiβ HJ. Red blood cells: their dual role in thrombus formation. Science 207: 541-543 1980;
• 14 Fernandex F, Goudable C, Sie P, Ton-That H, Durand D, Suc JM. Low haematocrit and prolonged bleeding times in uraemic patients: effect of red cell transfusions. Br J Haematol 59: 139-148 1985;
• 15 Längle M, Lackner FX, Madritsch M, Schwarz S, Watzl Ch, Granninger W, Hlozanek Ch. Der Einfluβ von hoch- und niedermolekularer Hydroxyäthylstärke auf die Blutgerinnung. Anaesthesist 38 (Suppl 2) 586 1989;
• 16 Dietrich G, Kretschmer V. Primary hemostasis in hemodilution 2. influence of various infusion solutions. Infusionsther 17: 214-216 1990;
• 17 Kretschmer V, Huss B, Weber S, Bewarder S, Schulzki T, Köppler H, Heymanns J. A contribution to the indications for platelet transfusion and determination of its therapeutic efficacy. Transfus Sci 15: 361-369 1994;